Market

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
Read More

Related Posts

Trump administration says Europe risks 'civilisational erasure', drawing outcry

Trump administration says Europe risks 'civilisational ...

This Tesla move could help the EV maker shake a sales slump

This Tesla move could help the EV maker shake a sales s...

‘Soon, all commodity charts will look like gold.’ BofA’s Hartnett goes bullish on commodities.

‘Soon, all commodity charts will look like gold.’ BofA’...

US Treasury Secretary Bessent holds constructive call with China

US Treasury Secretary Bessent holds constructive call w...

Woodward director Sengstack sells $2.1m in shares

Woodward director Sengstack sells $2.1m in shares

Empire State Realty Trust declares Q4 dividend of $0.035 per share

Empire State Realty Trust declares Q4 dividend of $0.03...